US경제·CNBC Business RSS· 번역 중
AI가 열심히 번역 중이에요 🤖
곧 한글 번역본을 제공해드릴게요. 잠시만 기다려주세요!
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
2026.08.06 22:25
AI 감성 분석
숏 (매도 신호)롱 47%숏 53%
본 뉴스는 직원 복지 및 제약 비용과 관련된 운영 비용 증가를 강조하며, 기업 지출에 약간의 부정적인 압력을 가하고 있습니다.
핵심 요약
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
Original Article
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
Source: https://www.cnbc.com/2026/08/05/bank-of-america-ceo-glp-1-drugs-cost.html